Item 8.01 Other Events.

On January 4, 2023, Know Labs, Inc. (the "Company") published a press release disclosing details on a new foundational patent granted by the United States Patent and Trademark Office. U.S. Patent No. 11,529,077, titled High Performance Glucose Sensor. This patent equates the Company's Bio-RFIDTM diagnostic technology to the current reference standard for glucose monitoring, widely used by diabetes researchers, hospital labs and glucometer manufacturers, and establishes a specific, superior benchmark range of clinical accuracy, known as MARD, for the Bio-RFID diagnostic platform.

The new patent extends the Know Labs IP portfolio to nearly 90 patents issued and pending, reinforcing the Company's position as a top worldwide IP holder in non-invasive blood glucose monitoring.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.




Item 9.01   Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.   Description of Exhibit
99.1            Press Release dated January 4, 2023   - Filed herewith.




                                     - 2 -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses